Does phenylketonuria have a distinctive facial appearance?

Written by Tong Peng
Pediatrics
Updated on March 04, 2025
00:00
00:00

Phenylketonuria is characterized by a specific facial appearance, primarily presenting with pale skin and yellow hair. Some affected children may develop eczema due to a disruption in melanin synthesis, which results in a distinctive skin color. Additionally, there are neuropsychiatric abnormalities, such as intellectual disability, increased excitability, and heightened muscle tone. The urine of patients has a plastic-like smell, largely because phenylketonuria is a hereditary metabolic disease. Newborns exhibit hyperphenylalaninemia, but as harmful metabolites of phenylalanine are not present in high concentrations before feeding begins, initial conditions at birth are often normal. However, as diet is introduced and metabolite concentrations increase, specific clinical symptoms, including severe cases of epileptic seizures manifested as infantile spasms, nodding seizures, or other forms, become evident. Therefore, dietary management is essential in treatment.

Other Voices

doctor image
home-news-image
Written by Yan Xin Liang
Pediatrics
53sec home-news-image

How is phenylketonuria tested?

Phenylketonuria is a treatable inherited metabolic disease, and early diagnosis is essential for early treatment. Currently, we have generally implemented a newborn disease screening system that requires collecting peripheral blood by pricking the heel of newborns after three days of breastfeeding, dropping the blood onto specialized filter paper and sending it to a screening laboratory for phenylalanine concentration measurement. If the concentration exceeds the confirmed value, further differential diagnosis and confirmation are needed. If treatment can begin early, especially within two to three weeks after birth, the prognosis is generally good. Normally, the concentration is less than 120 µmol/L; a fetal concentration of 1200 µmol/L would be considered mild phenylketonuria.

doctor image
home-news-image
Written by Yan Xin Liang
Pediatrics
1min 34sec home-news-image

The causes of phenylketonuria

Phenylketonuria is a common autosomal recessive genetic disorder, the most frequent primary clinical manifestation among congenital amino acid metabolic disorders. It is characterized by intellectual disability, pale skin and hair pigmentation, and a mouse urine-like odor. The main cause is that phenylalanine is an essential amino acid for the human body. The phenylalanine ingested is partly used for protein synthesis and partly converted to tyrosine by the action of phenylalanine hydroxylase, which is necessary for the synthesis of substances like adrenaline, melanin, and thyroxine. The disease is mainly due to a deficiency of phenylalanine hydroxylase, which inhibits the conversion of phenylalanine to tyrosine, resulting in increased concentrations of phenylalanine in the blood, cerebrospinal fluid, and various tissues. At the same time, due to the predominance of the main pathway, the enhancement of the secondary metabolic pathway leads to the deamination of phenylalanine by transaminase, producing a large amount of phenylpyruvic acid, which through oxidation produces a large amount of phenylacetic acid, phenyllactic acid, and p-hydroxyphenylpyruvic acid. These metabolic by-products are excreted in large quantities in the urine, and the high concentrations of phenylalanine and its by-products accumulate extensively in brain tissue, thereby causing damage to brain cells.

doctor image
home-news-image
Written by Yan Xin Liang
Pediatrics
1min 21sec home-news-image

The pathogenesis of phenylketonuria

Phenylketonuria is an autosomal recessive genetic disorder. Phenylalanine, which is an essential amino acid required by the human body, is partly used for protein synthesis after ingestion and partly converted into tyrosine via the action of phenylalanine hydroxylase, which is necessary for the synthesis of substances such as adrenaline, melanin, and thyroxine. Phenylketonuria is mainly caused by a deficiency of phenylalanine hydroxylase, which prevents the conversion of phenylalanine to tyrosine. This leads to increased levels of phenylalanine in the blood, cerebrospinal fluid, and various tissues. Additionally, as the primary metabolic pathway is blocked, secondary metabolic pathways are enhanced. Under the action of transaminases, phenylalanine undergoes deamination to produce large quantities of phenylpyruvic acid, which is further metabolized to produce phenylacetic acid, phenyllactic acid, and p-hydroxyphenylpyruvic acid, among other byproduct metabolites. These are excreted in large amounts in the urine. The high concentration of phenylalanine and its byproduct metabolites accumulates in brain tissue, leading to damage to brain cells and resulting in a range of clinical symptoms.

doctor image
home-news-image
Written by Hu Qi Feng
Pediatrics
40sec home-news-image

Phenylketonuria inheritance mode

Phenylketonuria is an autosomal recessive genetic disorder, caused by a mutation in the phenylalanine hydroxylase gene leading to reduced enzyme activity. This results in the accumulation of phenylalanine and its metabolic products in the body, causing the disease. It is the most common congenital amino acid metabolism disorder and is clinically characterized by delayed intellectual development, changes in skin and hair pigmentation, and a mousy urine odor. The incidence of this disease in China is approximately 1 in 11,000, and it is inherited in an autosomal recessive manner.

doctor image
home-news-image
Written by Hu Qi Feng
Pediatrics
43sec home-news-image

Mechanism of phenylketonuria

Phenylketonuria is characterized by reduced activity of phenylalanine hydroxylase, which fails to convert phenylalanine to tyrosine, causing extremely elevated levels of phenylalanine in the blood, cerebrospinal fluid, and tissues. This leads to the production of large amounts of phenylpyruvic acid, phenylacetic acid, phenyllactic acid, and p-hydroxyphenylacetic acid via alternative pathways. High concentrations of phenylalanine and its metabolic products can cause brain damage, which manifests as developmental intellectual disabilities, changes in skin and hair pigmentation, and a mousy urine odor, all part of a clinical syndrome.